abstract |
The present invention relates to a transgenic non-human animal or its offspring containing a gene encoding an antibody molecule and producing a composition of antibodies with modified complex carbohydrate chains. The specified composition of antibodies has a higher antibody-dependent cellular cytotoxicity than an antibody obtained from the parent cell line. The invention also relates to a method for producing said antibody composition and a medicament containing said antibody composition. |